ICOTF
iCo Therapeutics Inc

18
Mkt Cap
$135.76M
Volume
18,583.00
52W High
$0.935
52W Low
$0.3774
PE Ratio
-3.55
ICOTF Fundamentals
Price
$0.3956
Prev Close
$0.3977
Open
$0.3956
50D MA
$0.5028
Beta
0.35
Avg. Volume
73,230.62
EPS (Annual)
-$0.1787
P/B
2.53
Rev/Employee
$0.00
Loading...
Loading...
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14

Frequently Asked Questions

What is Market Cap of Satellos Bioscience Inc?
What is the 52-week high for Satellos Bioscience Inc?
What is the 52-week low for Satellos Bioscience Inc?
What is Satellos Bioscience Inc stock price today?
What was Satellos Bioscience Inc stock price yesterday?
What is the PE ratio of Satellos Bioscience Inc?
What is the Price-to-Book ratio of Satellos Bioscience Inc?
What is the 50-day moving average of Satellos Bioscience Inc?
How many employess does Satellos Bioscience Inc has?

Latest ICOTF News

View
No ICOTF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.